Tag: trial
Schuerger Shunnarah Trial Attorneys Open New Office to Go to War...
Indianapolis, IN, June 07, 2023 (GLOBE NEWSWIRE) -- Schuerger Shunnarah Trial Attorneys, reputed Indianapolis personal injury lawyers, are pleased to announce...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Funko (FNKO) Investors with …...
SAN FRANCISCO, June 05, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Funko, Inc. FNKO investors who suffered substantial losses submit your...
S INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages SentinelOn… –...
SAN FRANCISCO, June 05, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges SentinelOne, Inc. S investors who suffered substantial losses submit your...
NexImmune Presents Initial Positive Data from the NEXI-001 Phase 1 Trial...
- Trial includes high risk AML patients that have relapsed post allo-HSCT and are refractory to salvage therapy- NEXI-001 is well tolerated with...
ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages Bowlero Corp. Investors to Inquire A…...
NEW YORK, June 3, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims...
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Nutanix, Inc. Investors to Secure Coun…...
NEW YORK, May 31, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of...
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Hesai Group Investors with Losses to...
NEW YORK, May 28, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of...
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Fulcrum Therapeutics, Inc. Investors w… –...
NEW YORK, May 27, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of...
ROSEN, NATIONAL TRIAL COUNSEL, Encourages The Walt Disney Company Investors with…...
NEW YORK, May 24, 2023 /PRNewswire/ --WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of The...
Salubris Biotherapeutics Presents Positive Updates from Phase 1b Clinical Trial …...
After a Single Administration of JK07, Patients in All Dose Cohorts Showed Improvement in Ejection Fraction (EF) Through Day 90
JK07 was Generally Safe...